VivoSim Labs, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
VivoSim Labs, Inc. (VIVS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 2.55 thousand shares for the 12-month period ending 2026-03-31, per its 10-K filed 2026-07-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-07-14
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-06-30 was 0.00 shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2023-03-31 was 1.84K shares.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-12-31 was 6.09K shares, a 69.54% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2022-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2026 was 2.55K shares, a 80.24% decline from fiscal 2025.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2025 was 12.91K shares, a 98.62% decline from fiscal 2024.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 937.37K shares, a 11723.51% increase from fiscal 2023.
- VivoSim Labs, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 7.93K shares, a 97.88% decline from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | 2.55K shares 10-K · filed 2026-07-14 | |||
| 2025-03-31 | 12.91K shares 10-K · filed 2025-06-05 | |||
| 2024-03-31 | 937.37K shares 10-K · filed 2024-05-31 | |||
| 2023-06-30 | 0.00 shares 10-Q · filed 2023-08-10 | 1.84K shares derived: sum of 2 quarters · filed 2023-08-10 | 7.93K shares derived: sum of 3 quarters · filed 2023-08-10 | 7.93K shares derived: sum of 4 quarters · filed 2023-08-10 |
| 2023-03-31 | 1.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | 7.93K shares derived: sum of 2 quarters · filed 2023-07-14 | 7.93K shares derived: sum of 3 quarters · filed 2023-07-14 | 7.93K shares 10-K · filed 2023-07-14 |
| 2022-12-31 | 6.09K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-09 | 6.09K shares derived: sum of 2 quarters · filed 2023-02-09 | 6.09K shares 10-Q · filed 2023-02-09 | 6.09K shares derived: sum of 4 quarters · filed 2023-02-09 |
| 2022-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-10 | 0.00 shares 10-Q · filed 2022-11-10 | 0.00 shares derived: sum of 3 quarters · filed 2022-11-10 | 20.00K shares derived: sum of 4 quarters · filed 2022-11-10 |
| 2022-06-30 | 0.00 shares 10-Q · filed 2022-08-11 | 0.00 shares derived: sum of 2 quarters · filed 2022-08-11 | 20.00K shares derived: sum of 3 quarters · filed 2022-08-11 | 353.82K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | 20.00K shares derived: sum of 2 quarters · filed 2022-06-10 | 353.82K shares derived: sum of 3 quarters · filed 2022-06-10 | 374.53K shares 10-K · filed 2022-06-10 |
| 2021-12-31 | 20.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | 353.82K shares derived: sum of 2 quarters · filed 2022-02-14 | 374.53K shares 10-Q · filed 2022-02-14 | 383.78K shares derived: sum of 4 quarters · filed 2022-02-14 |
| 2021-09-30 | 333.82K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-08 | 354.53K shares 10-Q · filed 2021-11-08 | 363.78K shares derived: sum of 3 quarters · filed 2021-11-08 | 471.93K shares derived: sum of 4 quarters · filed 2021-11-08 |
| 2021-06-30 | 20.71K shares 10-Q · filed 2021-08-06 | 29.96K shares derived: sum of 2 quarters · filed 2021-08-06 | 138.11K shares derived: sum of 3 quarters · filed 2021-08-06 | 138.11K shares derived: sum of 4 quarters · filed 2021-08-06 |
| 2021-03-31 | 9.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | 117.40K shares derived: sum of 2 quarters · filed 2021-06-15 | 117.40K shares derived: sum of 3 quarters · filed 2021-06-15 | 117.40K shares 10-K · filed 2021-06-15 |
| 2020-12-31 | 108.15K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-02-08 | 108.15K shares derived: sum of 2 quarters · filed 2021-02-08 | 108.15K shares 10-Q · filed 2021-02-08 | 1.84M shares derived: sum of 4 quarters · filed 2021-02-08 |
| 2020-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-11-05 | 0.00 shares 10-Q · filed 2020-11-05 | 1.73M shares derived: sum of 3 quarters · filed 2020-11-05 | 4.19M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 0.00 shares 10-Q · filed 2020-08-10 | 1.73M shares derived: sum of 2 quarters · filed 2020-08-10 | 4.19M shares derived: sum of 3 quarters · filed 2020-08-10 | 4.64M shares derived: sum of 4 quarters · filed 2020-08-10 |
| 2020-03-31 | 1.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | 4.19M shares derived: sum of 2 quarters · filed 2020-05-28 | 4.64M shares derived: sum of 3 quarters · filed 2020-05-28 | 4.74M shares 10-K · filed 2020-05-28 |
| 2019-12-31 | 2.46M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-02-10 | 2.91M shares derived: sum of 2 quarters · filed 2020-02-10 | 3.02M shares 10-Q · filed 2020-02-10 | 4.01M shares derived: sum of 4 quarters · filed 2020-02-10 |
| 2019-09-30 | 457.47K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-11-07 | 558.54K shares 10-Q · filed 2019-11-07 | 1.56M shares derived: sum of 3 quarters · filed 2019-11-07 | 2.81M shares derived: sum of 4 quarters · filed 2019-11-07 |
| 2019-06-30 | 101.08K shares 10-Q · filed 2019-08-08 | 1.10M shares derived: sum of 2 quarters · filed 2019-08-08 | 2.35M shares derived: sum of 3 quarters · filed 2019-08-08 | 4.98M shares derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | 998.29K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | 2.25M shares derived: sum of 2 quarters · filed 2019-06-03 | 4.88M shares derived: sum of 3 quarters · filed 2019-06-03 | 5.50M shares 10-K · filed 2019-06-03 |
| 2018-12-31 | 1.25M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-07 | 3.88M shares derived: sum of 2 quarters · filed 2019-02-07 | 4.50M shares 10-Q · filed 2019-02-07 | 5.80M shares derived: sum of 4 quarters · filed 2019-02-07 |
| 2018-09-30 | 2.63M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | 3.25M shares 10-Q · filed 2018-11-08 | 4.55M shares derived: sum of 3 quarters · filed 2018-11-08 | 5.45M shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 614.07K shares 10-Q · filed 2018-08-09 | 1.91M shares derived: sum of 2 quarters · filed 2018-08-09 | 2.82M shares derived: sum of 3 quarters · filed 2018-08-09 | 3.15M shares derived: sum of 4 quarters · filed 2018-08-09 |
| 2018-03-31 | 1.30M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | 2.20M shares derived: sum of 2 quarters · filed 2018-05-31 | 2.53M shares derived: sum of 3 quarters · filed 2018-05-31 | 2.69M shares 10-K · filed 2018-05-31 |
| 2017-12-31 | 901.17K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-08 | 1.23M shares derived: sum of 2 quarters · filed 2018-02-08 | 1.39M shares 10-Q · filed 2018-02-08 | 1.47M shares derived: sum of 4 quarters · filed 2018-02-08 |
| 2017-09-30 | 332.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | 493.05K shares 10-Q · filed 2017-11-09 | 564.77K shares derived: sum of 3 quarters · filed 2017-11-09 | 804.27K shares derived: sum of 4 quarters · filed 2017-11-09 |
| 2017-06-30 | 160.46K shares 10-Q · filed 2017-08-09 | 232.18K shares derived: sum of 2 quarters · filed 2017-08-09 | 471.68K shares derived: sum of 3 quarters · filed 2017-08-09 | 505.67K shares derived: sum of 4 quarters · filed 2017-08-09 |
| 2017-03-31 | 71.72K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | 311.22K shares derived: sum of 2 quarters · filed 2017-06-07 | 345.20K shares derived: sum of 3 quarters · filed 2017-06-07 | 368.17K shares 10-K · filed 2017-06-07 |
| 2016-12-31 | 239.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | 273.48K shares derived: sum of 2 quarters · filed 2017-02-09 | 296.45K shares 10-Q · filed 2017-02-09 | 340.62K shares derived: sum of 4 quarters · filed 2017-02-09 |
| 2016-09-30 | 33.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03 | 56.95K shares 10-Q · filed 2016-11-03 | 101.12K shares derived: sum of 3 quarters · filed 2016-11-03 | 208.36K shares derived: sum of 4 quarters · filed 2016-11-03 |
| 2016-06-30 | 22.97K shares 10-Q · filed 2016-08-04 | 67.14K shares derived: sum of 2 quarters · filed 2016-08-04 | 174.37K shares derived: sum of 3 quarters · filed 2016-08-04 | 348.67K shares derived: sum of 4 quarters · filed 2016-08-04 |
| 2016-03-31 | 44.17K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | 151.40K shares derived: sum of 2 quarters · filed 2016-06-09 | 325.69K shares derived: sum of 3 quarters · filed 2016-06-09 | 349.70K shares 10-K · filed 2016-06-09 |
| 2015-12-31 | 107.23K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-08 | 281.53K shares derived: sum of 2 quarters · filed 2016-02-08 | 305.53K shares 10-Q · filed 2016-02-08 | 315.93K shares derived: sum of 4 quarters · filed 2016-06-09 |
| 2015-09-30 | 174.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-09 | 198.30K shares 10-Q · filed 2015-11-09 | 208.70K shares derived: sum of 3 quarters · filed 2016-06-09 | 222.02K shares derived: sum of 4 quarters · filed 2016-06-09 |
| 2015-06-30 | 24.00K shares 10-Q · filed 2015-08-10 | 34.41K shares derived: sum of 2 quarters · filed 2016-06-09 | 47.73K shares derived: sum of 3 quarters · filed 2016-06-09 | 47.73K shares derived: sum of 4 quarters · filed 2016-06-09 |
| 2015-03-31 | 10.40K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | 23.72K shares derived: sum of 2 quarters · filed 2016-06-09 | 23.72K shares derived: sum of 3 quarters · filed 2016-06-09 | 45.85K shares 10-K · filed 2016-06-09 |
| 2014-12-31 | 13.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | 13.32K shares derived: sum of 2 quarters · filed 2015-02-06 | 35.44K shares 10-Q · filed 2015-02-06 | 35.44K shares derived: sum of 4 quarters · filed 2015-06-09 |
| 2014-09-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07 | 22.13K shares 10-Q · filed 2014-11-07 | 22.13K shares derived: sum of 3 quarters · filed 2015-06-09 | 29.73K shares derived: sum of 4 quarters · filed 2015-06-09 |
| 2014-06-30 | 22.13K shares 10-Q · filed 2014-08-08 | 22.13K shares derived: sum of 2 quarters · filed 2015-06-09 | 29.73K shares derived: sum of 3 quarters · filed 2015-06-09 | |
| 2014-03-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-06-09 | 7.60K shares derived: sum of 2 quarters · filed 2015-06-09 | 18.45K shares 10-K · filed 2015-06-09 | |
| 2013-12-31 | 7.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | 18.45K shares 10-Q · filed 2014-02-06 | ||
| 2013-09-30 | 10.86K shares 10-Q · filed 2013-11-08 | |||
| 2012-12-31 | 5.00K shares 10-K · filed 2014-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |